Magazine Article | August 3, 2020

5 Considerations When Moving From Big Pharma To Biotech

Source: Life Science Leader

By Bill Hinshaw

I’ve had a fulfilling 25-year career in the pharmaceutical industry. During that time, I’ve worked for a couple of powerhouse companies, including Novartis, where I spent 15 years leading business units for oncology, transplant, infectious disease, specialty pharmaceuticals, consumer healthcare, over-the-counter, generics, and vaccines. Over the past decade there has been a tremendous amount of innovation happening in the startup realm, which piqued my interest in making a career move and in bringing cutting-edge therapies to patients in need.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: